These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11408756)

  • 1. Insulin-like growth factor -I deficiency.
    Camacho-Hübner C; Savage M
    Horm Res; 2001; 55 Suppl 1():17-20. PubMed ID: 11408756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of somatomedin-1: yes or no?
    Laron Z
    Paediatr Drugs; 1999; 1(3):155-9. PubMed ID: 10937448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The History of the Insulin-Like Growth Factor System.
    Miller BS; Rogol AD; Rosenfeld RG
    Horm Res Paediatr; 2022; 95(6):619-630. PubMed ID: 36446332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF
    BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular mechanisms of GH resistance.
    Rosenfeld RG; Hwa V
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S11-5. PubMed ID: 15339238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure.
    Hwa V; Haeusler G; Pratt KL; Little BM; Frisch H; Koller D; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 May; 91(5):1826-31. PubMed ID: 16507628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like Growth Factors in a clinical setting: Review of IGF-I.
    Frysak Z; Schovanek J; Iacobone M; Karasek D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):347-51. PubMed ID: 26365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral regulation of the growth hormone-insulin-like growth factor system in fish and other vertebrates.
    Reindl KM; Sheridan MA
    Comp Biochem Physiol A Mol Integr Physiol; 2012 Nov; 163(3-4):231-45. PubMed ID: 22909791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological & physiological aspects of action of insulin-like growth factor peptide family.
    Pavelić J; Matijević T; Knezević J
    Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
    Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone insensitivity syndromes: lessons learned and opportunities missed.
    Rosenfeld RG; Buckway CK
    Horm Res; 2001; 55 Suppl 2():36-9. PubMed ID: 11684874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.
    Ernst M; Rodan GA
    Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-like growth factors and growth disorders of childhood.
    Backeljauw PF; Chernausek SD
    Endocrinol Metab Clin North Am; 2012 Jun; 41(2):265-82, v. PubMed ID: 22682630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.